PHP
VTRS icon

Parkman Healthcare Partners’s Viatris VTRS Stock Holding History

Parkman Healthcare Partners’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Buy
+200,000
New +$3.1M 0.33% 66

Other funds holding VTRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Parkman Healthcare Partners's VTRS Position: Q2 2026 in Review

Parkman Healthcare Partners opened a new position in Viatris (VTRS) in Q2 2026: 200,000 shares worth $3.18M. The stake represents 0.33% of the portfolio and ranks #66 among its holdings.

1,022 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Parkman Healthcare Partners held 200,000 shares of Viatris worth $3.18M as of Q2 2026.
  • Viatris was a new Parkman Healthcare Partners position in Q2 2026.
  • Viatris made up 0.33% of Parkman Healthcare Partners's portfolio in Q2 2026, its #66 holding.
  • 1,022 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.